Patent classifications
A61B5/0515
Imaging of intelligent magnetic particles
An apparatus and method apply magnetic fields by generators external to a body or body part with sensors within an in vivo source that are sensitive to applied magnetic fields Through the use of these applied magnetic fields and sensitive sensors, disclosed embodiments can realize much better spatial resolution than is conventionally possible.
SENSOR SYSTEM, IN PARTICULAR FOR DETERMINING A GLUCOSE CONCENTRATION
A medical sensor system (1) for determining a feature in a human or animal body includes magnetic measurement nanoparticles (10) configured to form reversible chemical bonds with a binding substance, and experience a change in their magnetic relaxation behavior dependent on the formation of such bonds. The sensor system (i) further includes magnetic reference nanoparticles (20) having lesser (and preferably no) binding affinity to the binding substance.
Colon screening by using magnetic particle imaging
A method for colon screening and collecting data by using Magnetic Particle Imaging wherein an imaging magnetic field is generated with a spatial distribution of the magnetic field strength such that the area of examination in the colon consists of a first sub-area with lower magnetic field strength, where the magnetization of a magnetic particle which was pre-delivered to the colon is not saturated, and a second sub-area with a higher magnetic field strength, where the magnetization of said magnetic particle is saturated. The spatial location of both sub-areas in the area of examination is modified so that the magnetization of said particles changes locally. Signals are acquired and are evaluated to obtain information about the spatial distribution of the signals in the area of examination. The method may be carried out during an entire peristaltic cycle in a colon portion or segment.
Methods and apparatus for network localization of neurological symptoms from focal brain lesions
Methods and apparatus for providing a functional mapping of a brain lesion in a patient's brain. The method comprises determining using a computer processor, based on human connectome data stored on at least one computer datastore in communication with the computer processor, at least one functional network associated with a location of a brain lesion identified in an image of a patient's brain. The at least one functional network includes a plurality of brain areas functionally connected to the location of the brain lesion and a plurality of correlation measures. Each of the correlation measures indicates a strength of functional connection between the location of the brain lesion and a respective brain area of the plurality of brain areas in the at least one functional network. The method further comprises determining, based at least one functional network, a likelihood that the brain lesion is causing one or more patient symptoms.
Topogram prediction from surface data in medical imaging
For topogram predication from surface data, a sensor captures the outside surface of a patient. A generative adversarial network (GAN) generates the topogram representing an interior organ based on the outside surface of the patient. To further adapt to specific patients, internal landmarks are used in the topogram prediction. The topogram generated by one generator of the GAN may be altered based on landmarks generated by another generator.
Topogram prediction from surface data in medical imaging
For topogram predication from surface data, a sensor captures the outside surface of a patient. A generative adversarial network (GAN) generates the topogram representing an interior organ based on the outside surface of the patient. To further adapt to specific patients, internal landmarks are used in the topogram prediction. The topogram generated by one generator of the GAN may be altered based on landmarks generated by another generator.
Methods for magnetic particle capture and separation
Methods of exerting magnetic forces to separate magnetic particles disposed in a portion of subsurface vasculature using a wearable device are provided. The magnetic forces can act to attract, slow, speed, or otherwise influence the magnetic particles in various applications. In some examples, different magnetic forces are exerted on respective sets of magnetic particles to separate the respective sets of magnetic particles. In some examples, similar magnetic forces are exerted on sets of magnetic particles, and separation of the sets of magnetic particles is related to properties of the sets of magnetic particles and/or of the environment of the sets of magnetic particles. In some embodiments, the magnetic particles are configured to bind to an analyte of interest. The separation of the magnetic particles can enable detection of one or more properties of the analyte, modification of the analyte, and/or extraction of the analyte bound to the magnetic particles.
Magnetic-field-generating coil system, imaging system having magnetic-field-generating coil system, and method for operating imaging system
Disclosed herein are a magnetic-field-generating coil system, an imaging system having the magnetic-field-generating coil system, and a method for operating the imaging system. The method for operating an imaging system includes generating multiple Linear Gradient Fields (LGFs) in respective axial directions by controlling coil currents, and acquiring MRI information or Magnetic Particle Imaging (MPI) information about an object while moving the multiple LGFs by varying the coil currents.
SYSTEMS AND METHODS FOR IMAGING
A method of imaging an organism includes introducing a composite nanoparticle into a circulating fluid of an organism to form a circulating fluid mixture in the organism is provided. The composite nanoparticle comprises a core comprising at least one of a contrast agent and a magnetic material, and at least one layer of biocompatible material surrounding the core. The method further includes receiving an image of at least a portion of the organism where the circulating fluid has circulated, removing at least a portion of the circulating fluid mixture from the organism at a first rate, applying a magnetic field to the removed portion of the circulating fluid mixture to selectively remove the composite nanoparticle from the circulating fluid mixture and to produce a filtered fluid mixture, and returning the filtered fluid mixture to the circulating fluid of the organism at a second rate.
BIOMAGNETISM MEASUREMENT DEVICE
A biomagnetism measurement device includes a tubular body, an inflatable portion inflatable upon supply of gas, and a magnetic sensor portion that detects a magnetic field from outside the tubular body. The inflatable portion is located at a required region of the tubular body, and the magnetic sensor portion is fixed to an inner wall of the inflatable portion. The tubular body and the inflatable portion include the same material, and the wall thickness of the inflatable portion is thinner than that of the tubular body.